By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Bellicum Pharmaceuticals, Inc. 

2 Greenway Plaza
Suite 1380
Houston  Texas  77046  U.S.A.
Phone: 713-798-8670 Fax: 713-798-4950



Company News
Bellicum (BLCM) Licenses TCR Technology From Leiden University Medical Center 4/30/2015 10:29:28 AM
Bellicum (BLCM) Provides Operational Update And Reports Financial Results For Fourth Quarter And Year Ended December 31, 2014 3/12/2015 11:57:50 AM
Bellicum (BLCM) To Report Fourth Quarter And Full Year 2014 Financial Results On March 11, 2015 3/4/2015 7:25:21 AM
Fresh Off Its $140 Million IPO, Bellicum (BLCM) Lays Out Hiring Plans 2/26/2015 6:46:04 AM
Bellicum Pharmaceuticals, Inc. To Present At The 2015 Leerink Global Healthcare Conference 2/4/2015 9:18:46 AM
Bellicum Pharmaceuticals, Inc. Announces Successful Dosing Of First Patient Cohort With BPX-501 T Cells Following Haplo-Identical Hematopoietic Stem Cell Transplant 1/13/2015 11:49:29 AM
Bellicum Pharmaceuticals, Inc. Announces Closing Of Initial Public Offering And Exercise Of The Underwriters’ Option 12/24/2014 8:57:55 AM
Nasdaq Welcomes Bellicum Pharmaceuticals, Inc. To The Nasdaq Stock Market 12/19/2014 7:33:02 AM
Bellicum Pharmaceuticals, Inc. Prices Initial Public Offering Of 7,350,000 Shares Of Common Stock 12/18/2014 11:50:19 AM
Houston-Based Bellicum Pharmaceuticals, Inc. Sets Terms For $100 Million IPO 12/12/2014 6:08:31 AM